Home » Topics » Regulatory » Patents

Patents
RSS

PKC inhibitors under study at Hoechst Marion Roussel

Feb. 20, 1998

Selective dopamine D3 ligands described by P&U

Feb. 20, 1998

Allergan's new antiglaucoma agents

Feb. 20, 1998

Neurocrine Biosciences describes compounds for increasing endogenous neuropeptide levels

Feb. 20, 1998

Warner-Lambert reveals new antipsychotic benzoxazinones

Feb. 20, 1998

Oxcarbazepine derivatives with potent anticonvulsant activity

Feb. 20, 1998

Hoechst prepares xanthines for cerebrovascular disorders

Feb. 19, 1998

Lilly claims thrombin inhibitors

Feb. 19, 1998

New natural or semisynthetic cytotoxic alkaloids from Indena

Feb. 19, 1998

New cell adhesion inhibitors from Shionogi

Feb. 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...